ClinicalTrials.Veeva

Menu

Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

G

General Hospital of Northern Theater Command of Chinese People's Liberation Army

Status

Completed

Conditions

Stroke, Ischemic

Treatments

Device: endovascular treatment

Study type

Observational

Funder types

Other

Identifiers

NCT05092139
y (2021) 077

Details and patient eligibility

About

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

Enrollment

3,000 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: ≥ 18;
  • Ischemic stroke confirmed by head CT or MRI;
  • Patients receiving endovascular treatment;
  • First ever stroke or pre-stroke mRS≤2;
  • signed informed consent.

Exclusion criteria

  • Prestroke mRS≥3;
  • Other serious illness that would confound the clinical outcome at 90 days;
  • Unavailable neuroimaging data;
  • Other unsuitable conditions judged by the investigator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems